Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bulletin Du Cancer|July 8, 2025
Development and evaluation of a new protocol for the management of immediate hypersensitivity reactions in an oncology outpatient departmentPierre-Yves Cren, Géraldine Rosier, Nicolas Penel, et al.
BMJ Open|January 25, 2018
Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers treated with first-line chemotherapy: a randomised phase III trialEmilie Hutt, Arlette Da Silva, Emilie Bogart, et al.
Oncology Letters|July 23, 2016
High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancerDiane Pannier, Géraldine Philippin-Lauridant, Marie-Christine Baranzelli, et al.
Anticancer Research|May 7, 2013
Prolonged survival of patients with breast cancer-related leptomeningeal metastasesEmilie Le Rhun, Sophie Taillibert, Fahed Zairi, et al.
BMC Cancer|August 2, 2018
Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trialDiane Pannier, Antoine Adenis, Emilie Bogart, et al.
Anticancer Research|June 10, 2019
Brain Metastasis and Renal Cell Carcinoma: Prognostic Scores Assessment in the Era of Targeted TherapiesZiad El Ali, Sylvie Rottey, Philippe Barthelemy, et al.
International Journal of Cancer|March 8, 2023
Pain in desmoid-type fibromatosis: Prevalence, determinants and prognosis valueNicolas Penel, Sylvie Bonvalot, Marie-Cécile Le Deley, et al.
British Journal of Cancer|February 6, 2026
Exposure-response relationship of nivolumab and ipilimumab in patients with metastatic renal cell carcinoma from the randomised phase 2 BIONIKK studyBenoit Blanchet, Alicja Puszkiel, Anne Jouinot, et al.
Nature Medicine|April 8, 2025
Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trialOlivier Trédan, Damien Pouessel, Nicolas Penel, et al.
Eclinicalmedicine|November 11, 2024
Early palliative care and overall survival in patients with metastatic upper gastrointestinal cancers (EPIC): a multicentre, open-label, randomised controlled phase 3 trialAntoine Adenis, Arlette Da Silva, Meher Ben Abdelghani, et al.
Pageof 3